In 2017, a review of microalgae protein‐derived bioactive peptides relevant in cardiovascular disease (CVD) management was published. Given the rapid evolution of the field, an update is needed to illumininate recent developments and proffer future suggestions. In this review, the scientific literature (2018–2022) is mined for that purpose and the relevant properties of the identified peptides related to CVD are discussed. The challenges and prospects for microalgae peptides are similarly discussed. Since 2018, several publications have independently confirmed the potential to produce microalgae protein‐derived nutraceutical peptides. Peptides that reduce hypertension (by inhibiting angiotensin converting enzyme and endothelial nitric oxide synthase), modulate dyslipidemia and have antioxidant and anti‐inflammatory properties have been reported, and characterized. Taken together, future research and development investments in nutraceutical peptides from microalgae proteins need to focus on the challenges of large‐scale biomass production, improvement in techniques for protein extraction, peptide release and processing, and the need for clinical trials to validate the claimed health benefits as well as formulation of various consumer products with the novel bioactive ingredients.
Medicinal Plants have demonstrated history of managing some ailments caused by free radicals as a result of some chemical constituents they possess. This study was aimed at assessing antioxidant and free radical scavenging properties of Tannin-rich and Flavoniod-rich fraction of Annona senegelensis and Vernonia amygdalina leaves via in vitro assays such as; reducing power, nitric oxide scavenging activity, Hydrogen peroxide scavenging activity and Lipid peroxidation scavenging activity. The results obtained indicated that both medicinal plants are antioxidant reservoir. The values for Tannin rich fraction of Annona senegelensis (TRFAS) and Tannin rich fraction of Vernonia amygdalina (TRFVA) are Reducing power absorbance TRFAS (0.077-0.187), TRFVA (0.168-0239). % Nitric oxide scavenging: TRFAS (4.46-30.40), TRFVA (5.23-42.24). % H2O2 scavenging: TRFAS (7.30-20.35), TRFVA (8.12-22.32). % Lipid Perioxidation: TRFAS (6.81-32.76), TRFVA (5.16-26.16). Also the values for Flavonoid rich fraction of Annona senegelensis (FRFAS) and Flavonoid rich fraction of Vernonia amygdalina (FRFVA) are reducing power absorbance: FRFAS (0.109-0.342), FRFVA (0.124-0.388). % Nitric oxide scavenging: FRFAS (33.55-43.57), FRFVA (21.10-47.46). % H2O2 scavenging: FRFAS (39.01-74.96), FRFVA (45.80-75.20). % Lipid Perioxidation: FRFAS (24.81-59.69), FRFVA (41.43-59.98). The Tannin-rich and Flavonoid-rich fraction of both plants exhibited good antioxidant activity on all models employed at increasing concentrations but Flavoniod-rich fraction of Vernonia amygdalina had the highest inhibitory effect than the Tannin fraction. The findings from this study validated the pharmacological potency of the two plants and their potential use in combating free radical-related diseases, which are often triggered by oxidative stress.
Emilia coccinea is widely used in folkloric medicine for eye and ear ailments as well as for fever. This present study evaluated the preliminary and quantitative phytochemical properties of E. coccinea leaves using standard procedures. The results revealed the following bioactive compounds Flavonoids (0.90 ± 0.02), Alkaloids (0.94 ± 0.03), Tannins (10.36 ± 0.02), Saponins (2.34 ± 0.02), Oxalate (1.62 ± 0.01), Phenols (0.89 ± 0.02), Terpenoids (0.11 ± 0.01). The high concentration of tannin and moderate concentration of other phytochemical proved that E. coccinea can serve as a vital medicinal plant that could be used for pharmaceutical formulations.
The purpose of the present study was to evaluate the laxative and antimicrobial activities of ethanol extracts of leaf and root of Amaranthus viridis L. The laxative activity of ethanolic leaf extract of A. viridis was studied using six groups of wistar albino rats; Group I which served as the negative control received 0.5ml/kg of normal saline, Group II received 10mg/kg of Dulcolax and the rest of the groups (III-VI) received 400, 200, 100 and 50mg/kg of the extract respectively. The laxative activity of the ethanolic leaf extract was expressed as the mean of total weight of faecal output in each group. A significant (p<0.05) dose dependent increase in the faecal output was observed at the 200mg/kg (3.00 ±1.41gm) and 400mg/kg (3.50 ±2.12gm) doses compared with the negative control. The antimicrobial activity was expressed as the diameter of the zone of inhibition hence the minimum inhibitory concentrations were determined. The antimicrobial activity of the A. viridis leaf and root extracts had dose dependent increases in all the tested organisms from their various minimum inhibitory concentrations (MIC). The result confirmed that the leaves and root of A. viridis possess laxative and antimicrobial activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.